Postmortem molecular screening for cardiac ryanodine receptor type 2 mutations in sudden unexplained death: R420W

Hajime Nishio1, Misa Iwata, Koichi Suzuki

  • 1Department of Legal Medicine, Osaka Medical College, Takatsuki 569-8686, Japan. leg010@art.osaka-med.ac.jp

Abstract

Insights

Cardiac ryanodine receptor type 2 (RyR2) gene mutations, specifically R420W, may cause sudden unexplained death (SUD). This RyR2 mutation was found in two autopsy cases, one with characteristics of status thymico-lymphaticus.

Area of Science:

  • Cardiovascular Genetics
  • Forensic Pathology
  • Molecular Biology

Background:

  • Mutations in the cardiac ryanodine receptor type 2 (RyR2) gene are linked to sudden cardiac death.
  • Effort-induced polymorphic ventricular arrhythmias, syncope, and sudden death are known consequences.

Purpose of the Study:

  • To investigate RyR2 gene mutations in autopsy cases of sudden unexplained death (SUD).
  • To explore potential links between RyR2 mutations and specific pathological findings.

Main Methods:

  • Screening of the RyR2 gene in 18 autopsy cases of SUD.
  • Analysis of genetic mutations and postmortem phenotypic characteristics.

Main Results:

  • Two cases (11%) revealed a heterozygous missense mutation (R420W) in exon 14 of the RyR2 gene.
  • Both mutation-positive cases exhibited mild fatty infiltration of the right ventricular apex.
  • One case presented with features consistent with status thymico-lymphaticus, including thymic enlargement and aortic narrowing; the second case showed some similar characteristics.

Conclusions:

  • The identified R420W RyR2 mutation, previously associated with juvenile sudden death, may be causative in these SUD cases.
  • Postmortem molecular screening of the RyR2 gene is a valuable tool for SUD investigations.
  • A potential association between RyR2 mutations and status thymico-lymphaticus warrants further discussion and research.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...